CLARINEX-D® 12 Hour Extended Release Tablets
CLARINEX-D®12 HOUR Extended
Release Tablets
Help take back control with new
CLARINEX-D® 12 HOUR Extended Release
Tablets.
CLARINEX® now offers powerful
congestion relief!
What is the most bothersome symptom of your morning allergies?
If you answered nasal congestion, you're not alone. In a survey of 1,000 adults
with allergic rhinitis, it was found that nearly 85 percent experience nasal
congestion when they first wake up, making it the most prevalent allergy
symptom in the morning. There is now a 12-hour formulation that combines the
proven efficiency and safety of CLARINEX®
with an established decongestant.
CLARINEX-D® 12 Hour Extended Release Tablets
help relieve nasal and non-nasal symptoms of seasonal allergic rhinitis
(outdoor allergies), including nasal congestion, in patients 12 years and
older. Ask your doctor about CLARINEX-D® 12
HOUR Extended Release Tablets -- and to help you say good-bye to morning
allergies
CLARINEX-D® 12 HOUR fits into
your life.
CLARINEX-D® 12 HOUR contains
a nonsedating antihistamine that does not carry any FDA precautions regarding
driving or alcohol consumption.
CLARINEX-D® 12 HOUR may be
taken without regard to meals.
CLARINEX-D® 12 HOUR is well
tolerated.
The formulation uses a bi-layer tablet delivery system, which
controls the release of the pseudoephedrine component for consistent delivery.
Taken twice daily, as recommended,
CLARINEX-D® 12 HOUR can help patients
control their nasal congestion, along with their sneezing, runny nose, itchy
throat, or itchy and watery eyes, in the morning and throughout the
day.
Due to its pseudoephedrine component,
CLARINEX-D® 12 HOUR Extended Release Tablets
should not be taken by patients with narrow-angle glaucoma (abnormally high eye
pressure), difficulty urinating, severe high blood pressure, or severe heart
disease, or by patients who have taken a monoamine oxidase (MAO) inhibitor
within the past fourteen (14) days. Patients with high blood pressure;
diabetes; heart disease; increased intraocular pressure (eye pressure);
thyroid, liver or kidney problems; or enlarged prostate should check with their
healthcare provider before taking
CLARINEX-D® 12 HOUR. Care should be used if
CLARINEX-D® 12 HOUR is taken with other
antihistamines or decongestants because combined effects on the cardiovascular
system may be harmful. The most commonly reported adverse events for
CLARINEX-D® 12 HOUR Extended Release Tablets
were insomnia, headache, dry mouth, fatigue, drowsiness, sore throat, and
dizziness.
CLARINEX®, a prescription medication, treats year-round allergy symptoms and ongoing hives of unknown cause, in adults and children 6 months and older, and seasonal allergy symptoms in patients 2 years and older. CLARINEX® 5 mg Tablets and 5 mg RediTabs® Tablets are approved for patients 12 years and older; CLARINEX® 2.5 mg RediTabs® Tablets are approved for patients 6 to 11 years; CLARINEX® Syrup is approved for patients 6 months and older.
Twice-daily CLARINEX-D® 12 HOUR Extended Release Tablets and once-daily CLARINEX-D® 24 HOUR Extended Release Tablets treat the symptoms of seasonal allergies, including nasal congestion, in patients 12 years and older.
IMPORTANT SAFETY INFORMATION
CLARINEX® Tablets side effects in patients 12 years and older were similar to placebo and included sore throat, dry mouth, and fatigue for seasonal and year-round allergy patients, and headache, nausea, and fatigue for patients with ongoing hives of unknown cause.
CLARINEX® Syrup side effects in children 6 to 11 years were similar to placebo. For children 6 months to 5 years, syrup side effects varied by age and included fever, diarrhea, upper respiratory infection, irritability, and coughing.
Due to their pseudoephedrine component, CLARINEX-D® 12 HOUR Extended Release Tablets and CLARINEX-D® 24 HOUR Extended Release Tablets should not be taken by patients with narrow-angle glaucoma (abnormally high eye pressure), difficulty urinating, severe high blood pressure, or severe heart disease, or by patients who have taken a monoamine oxidase (MAO) inhibitor within the past fourteen (14) days. Patients with high blood pressure; diabetes; heart disease; increased intraocular pressure (eye pressure); thyroid, liver or kidney problems; or enlarged prostate should check with their healthcare provider before taking CLARINEX-D® 12 HOUR Extended Release Tablets or CLARINEX-D® 24 HOUR Extended Release Tablets.
Care should be used if CLARINEX-D® 12 HOUR Extended Release Tablets or CLARINEX-D® 24 HOUR Extended Release Tablets are taken with other antihistamines or decongestants because combined effects on the cardiovascular system may be harmful. The most commonly reported adverse events for CLARINEX-D® 12 HOUR Extended Release Tablets were insomnia, headache, dry mouth, fatigue, drowsiness, sore throat, and dizziness. The most commonly reported adverse events for CLARINEX-D® 24 HOUR Extended Release Tablets were dry mouth, headache, insomnia, fatigue, sore throat, and drowsiness.
Click here for important CLARINEX® Tablets/Syrup/RediTabs® Product Information.
Click here for important CLARINEX-D® 12 HOUR Product Information.
Click here for important CLARINEX-D® 24 HOUR Product Information.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Note: The information on this site is not intended to be a substitute for professional medical advice. If you have any questions about your treatment or medical condition, please consult your doctor or other qualified health care provider. This site is intended for use by U.S. residents.
